BioHealth News Archive

NIAID: Gilead’s Remdesivir Shows Positive Proof of Concept in Hospitalized COVID-19 Patients

NIAID: Gilead’s Remdesivir Shows Positive Proof of Concept in Hospitalized COVID-19 Patients

Gilead Sciences’ closely-watched COVID-19 drug candidate remdesivir outperformed placebo in a clinical trial sponsored by the NIH’s National Institute of Allergy and Infectious Disease…

Read More
Gilson and QIAGEN Announce Collaboration Aiming to Make Manual Nucleic Acid Extraction More Efficient and Reproducible

Gilson and QIAGEN Announce Collaboration Aiming to Make Manual Nucleic Acid Extraction More Efficient and Reproducible

Gilson and QIAGEN have entered into a strategic partnership that will provide researchers the ability to limit operator-dependent variation in their manual nucleic acid…

Read More
NEA-backed Personal Genome Diagnostics receives FDA clearance for its cancer diagnostic | TechCrunch

NEA-backed Personal Genome Diagnostics receives FDA clearance for its cancer diagnostic | TechCrunch

Personal Genome Diagnostics, the venture-backed developer of a novel diagnostic kit for genomic profiling of different cancers in lab settings, has received clearance from…

Read More
Personal Genome Diagnostics Receives FDA Clearance for PGDx elio™ tissue complete, the First Comprehensive Genomic Profiling Diagnostic Kit for Oncology | Business Wire

Personal Genome Diagnostics Receives FDA Clearance for PGDx elio™ tissue complete, the First Comprehensive Genomic Profiling Diagnostic Kit for Oncology | Business Wire

BALTIMORE--(BUSINESS WIRE)--Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, announced today that the company has received market clearance from the U.S. Food…

Read More
LifeSprout, Inc. Closes $28.5 Million Series A Financing

LifeSprout, Inc. Closes $28.5 Million Series A Financing

BALTIMORE, Md., April 27, 2020 /PRNewswire/ -- LifeSprout, a privately-held regenerative medicine company founded with technology licensed from Johns Hopkins University, has closed a $28.5…

Read More
Gentian AS Seeking Collaborator to Test BioMarker Performance in Severe COVID-19 Cases

Gentian AS Seeking Collaborator to Test BioMarker Performance in Severe COVID-19 Cases

Gentian AS, a Norwegian company, with its US office at BioHealth Innovation in Rockville, Maryland is seeking collaborators to investigate if two of the…

Read More
Hard to Find Small Lab Space – Only Two Spaces Left! – Alexandria LaunchLabs™

Hard to Find Small Lab Space – Only Two Spaces Left! – Alexandria LaunchLabs™

Alexandria LaunchLabs™ in Maryland, will provide fully equipped, affordable laboratory/office space with flexible lease terms, supporting infrastructure, access to amenities, and supporting services and…

Read More
Innara Health and BHI Partner to Accelerate Company Growth

Innara Health and BHI Partner to Accelerate Company Growth

FDA Cleared Medical Device Improves Feeding Outcomes of Infants Born Prematurely Olathe, KS and Rockville, MD, April 28, 2020—Innara Health, developer of the only…

Read More
Governor Hogan Introduces Safe, Gradual, and Effective ‘Maryland Strong: Roadmap to Recovery’

Governor Hogan Introduces Safe, Gradual, and Effective ‘Maryland Strong: Roadmap to Recovery’

ANNAPOLIS, MD—After weeks of consulting with leading scientists, business leaders, and public health experts, Governor Larry Hogan today introduced the ‘Maryland Strong: Roadmap to Recovery,’ which…

Read More

Five takeaways from Gov. Larry Hogan’s plan to reopen Maryland – Baltimore Sun

Maryland Gov. Larry Hogan on Friday announced his three-phase plan to eventually reopen the state amid the coronavirus pandemic. Hogan called the plan a…

Read More
This physician-founder is making a device to protect medical staff during intubation procedures – Technical.ly Baltimore

This physician-founder is making a device to protect medical staff during intubation procedures – Technical.ly Baltimore

Working as an emergency and critical care physician at the University of Maryland School of Medicine, Dr. Steven Tropello is seeing the lack of…

Read More
Emergex Signs Agreement with GEORGE MASON UNIVERSITY for Highly Pathogenic RNA Virus Studies

Emergex Signs Agreement with GEORGE MASON UNIVERSITY for Highly Pathogenic RNA Virus Studies

Emergex Vaccines Holding Limited (‘Emergex’), a biotechnology company developing CD8+ priming set-point vaccines to prevent serious infectious diseases, today announced that it has entered…

Read More
Baltimore Company Will Produce COVID-19 Vaccine Under New Agreement With Johnson & Johnson | WBFF

Baltimore Company Will Produce COVID-19 Vaccine Under New Agreement With Johnson & Johnson | WBFF

A Baltimore company will be at the forefront of producing a potential coronavirus vaccine. Once a COVID-19 vaccine is ready for mass production, the…

Read More
AGT CEO Jeff Galvin on the Future of the Gene and Cell Therapy Industry | BioSpace

AGT CEO Jeff Galvin on the Future of the Gene and Cell Therapy Industry | BioSpace

The rapid growth of biopharma is causing a shift to a new paradigm for the drug development and delivery model. In the same manner…

Read More
Colleges make plans for bringing students back 2020 – The Washington Post

Colleges make plans for bringing students back 2020 – The Washington Post

In a different year, incoming freshmen would already have in hand a tightly choreographed schedule for late summer and early fall: the move-in date,…

Read More